Phosphoproteome Profiling of uEVs Reveals p-AQP2 and p-GSK3β as Potential Markers for Diabetic Nephropathy
Molecules · 2023
DOI: 10.3390/molecules28145605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Qing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200437, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Extracellular Vesicles, Diabetes Mellitus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2.0--1, Shanghai Science and Technology Innovation Action Plan, Shanghai Municipal Key Clinical Specialty.
Abstract (Originalsprache)
Diabetic nephropathy (DN) contributes to increased morbidity and mortality among patients with diabetes and presents a considerable global health challenge. However, reliable biomarkers of DN have not yet been established. Phosphorylated proteins are crucial for disease progression. However, their diagnostic potential remains unexplored. In this study, we used ultra-high-sensitivity quantitative phosphoproteomics to identify phosphoproteins in urinary extracellular vesicles (uEVs) as potential biomarkers of DN. We detected 233 phosphopeptides within the uEVs, with 47 phosphoproteins exhibiting significant alterations in patients with DN compared to those in patients with diabetes. From these phosphoproteins, we selected phosphorylated aquaporin-2 (p-AQP2[S256]) and phosphorylated glycogen synthase kinase-3β (p-GSK3β[Y216]) for validation, as they were significantly overrepresented in pathway analyses and previously implicated in DN pathogenesis. Both phosphoproteins were successfully confirmed through Phos-tag western blotting in uEVs and immunohistochemistry staining in kidney sections, suggesting that phosphoprotein alterations in uEVs reflect corresponding changes within the kidney and their potential as candidate biomarkers for DN. Our research proposes the utilization of phosphoproteins in uEVs as a liquid biopsy, presenting a highly feasible diagnostic tool for kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200437, China.
- Department of Nephrology, Sichuan Academy of Sciences & Sichuan Provincial People's Hospital, Sichuan Clinical Research Center for Kidney Disease, University of Electronic Science and Technology, Chengdu 610072, China.
- Department of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
- Key Laboratory of Carcinogenesis and Cancer Invasion, Liver Cancer Institute, Zhongshan Hospital, Minister of Education, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
ORCID-Profile: Jiong Zhang
Förderung
- 2.0--1
- Shanghai Science and Technology Innovation Action Plan
- Shanghai Municipal Key Clinical Specialty
- Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai Science and Technology Commission
- China National Key R&D Program during the 13th Five-year Plan Period
- China National Key R&D Program during the 14th Five-year Plan Period
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Li, Q., Zhang, J., Fang, Y., Dai, Y., Jia, P., Shen, Z., Xu, S., Ding, X., & Zhou, F. (2023). Phosphoproteome Profiling of uEVs Reveals p-AQP2 and p-GSK3β as Potential Markers for Diabetic Nephropathy. Molecules. https://doi.org/10.3390/molecules28145605
Vancouver
Li Q, Zhang J, Fang Y, Dai Y, Jia P, Shen Z, et al. Phosphoproteome Profiling of uEVs Reveals p-AQP2 and p-GSK3β as Potential Markers for Diabetic Nephropathy. Molecules. 2023. doi:10.3390/molecules28145605
BibTeX
@article{Li2023,
author = {Li, Qing and Zhang, Jiong and Fang, Yi and Dai, Yan and Jia, Ping and Shen, Ziyan and Xu, Sujuan and Ding, Xiaoqiang and Zhou, Feng},
title = {Phosphoproteome Profiling of uEVs Reveals p-AQP2 and p-GSK3β as Potential Markers for Diabetic Nephropathy},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28145605}
}
EUVIMED